Cargando…
Infiltrating myeloid cell diversity determines oncological characteristics and clinical outcomes in breast cancer
BACKGROUND: Breast cancer presents as one of the top health threats to women around the world. Myeloid cells are the most abundant cells and the major immune coordinator in breast cancer tumor microenvironment (TME), target therapies that harness the anti-tumor potential of myeloid cells are current...
Autores principales: | Yang, Chenxuan, Liu, Jiaxiang, Zhao, Shuangtao, Shang, Qingyao, Ren, Fei, Feng, Kexin, Zhang, Ruixuan, Kang, Xiyu, Wang, Xin, Wang, Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246424/ https://www.ncbi.nlm.nih.gov/pubmed/37287069 http://dx.doi.org/10.1186/s13058-023-01669-6 |
Ejemplares similares
-
An exploration of the correlations between seven psychiatric disorders and the risks of breast cancer, breast benign tumors and breast inflammatory diseases: Mendelian randomization analyses
por: Ren, Fei, et al.
Publicado: (2023) -
The prognostic value of IPI in patients with primary breast lymphoma, a multicenter retrospective study
por: Feng, Kexin, et al.
Publicado: (2022) -
Establishment and validation of a gasdermin signature to evaluate the immune status and direct risk‐group classification in luminal‐B breast cancer
por: Yang, Chenxuan, et al.
Publicado: (2021) -
Establishment and validation of a multigene model to predict the risk of relapse in hormone receptor-positive early-stage Chinese breast cancer patients
por: Liu, Jiaxiang, et al.
Publicado: (2023) -
Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity
por: Elliott, Louise A., et al.
Publicado: (2017)